75 reports of this reaction
4.0% of all CEFPODOXIME PROXETIL reports
#2 most reported adverse reaction
PYREXIA is the #2 most commonly reported adverse reaction for CEFPODOXIME PROXETIL, manufactured by Amici Pharmaceuticals, LLC.. There are 75 FDA adverse event reports linking CEFPODOXIME PROXETIL to PYREXIA. This represents approximately 4.0% of all 1,861 adverse event reports for this drug.
Patients taking CEFPODOXIME PROXETIL who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is moderately reported among CEFPODOXIME PROXETIL users, representing a notable but not dominant share of adverse events.
In addition to pyrexia, the following adverse reactions have been reported for CEFPODOXIME PROXETIL:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 75 FDA reports for CEFPODOXIME PROXETIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 4.0% of all adverse event reports for CEFPODOXIME PROXETIL, making it one of the most commonly reported side effect.
If you experience pyrexia while taking CEFPODOXIME PROXETIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.